Emiliya Akhundova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Emiliya Akhundova has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Aurore D. Zhang
Department of Dermatology, Boston University School of Medicine, 609 Albany St., J502, Boston, MA 02118, USA
1 shared publication - Candice E. Brem
Dermatopathology Section, Department of Dermatology, Boston University School of Medicine, 609 Albany St., J300, Boston, MA 02118, USA
1 shared publication - Eric J. Beltrami
Department of Dermatology, Boston University School of Medicine, 609 Albany St., J502, Boston, MA 02118, USA
1 shared publication - Henriette De La Garza
Drs. De La Garza, Trepanowski, Visutjindaporn, Patzelt, and Vashi are with the Department of Dermatology at the Boston University School of Medicine in Boston, Massachusetts
1 shared publication - Michelle Lazar
Department of Dermatology, Boston University School of Medicine, 609 Albany St., J502, Boston, MA 02118, USA
1 shared publication
Latest Publications
- Open Access
- 11 April 2025
- Published by MDPI AG in Dermatopathology
- Vol. 12 (2) , 13
A Scoping Review on Melasma Treatments and Their Histopathologic Correlates
Melasma is an incredibly common dyschromic disorder, mostly impacting women with skin of color. There are three variants of melasma based on the depth of pathologic involvement: epidermal, mixed, and dermal. While there are many treatments for melasma, there is a paucity of research on melasma treatments and their dermatopathological correlates. A scoping review was conducted of all human trials on melasma with histopathologic analysis, including 37 trials in the final analysis. Most studies were conducted on women with a Fitzpatrick skin type of III or greater. Strong histologic evidence supports the utilization of retinols/retinoids for epidermal melasma and microneedling for dermal melasma. There is a paucity of trials conducted on melasma utilizing histologic correlates, and fewer still that are comprehensive to include analyses on quality of life.
- 11 April 2025
- Published by MDPI AG in Dermatopathology
- Vol. 12 (2) , 13
Open AccessA Scoping Review on Melasma Treatments and Their Histopathologic Correlates
Melasma is an incredibly common dyschromic disorder, mostly impacting women with skin of color. There are three variants of melasma based on the depth of pathologic involvement: epidermal, mixed, and dermal. While there are many treatments for melasma, there is a paucity of research on melasma treatments and their dermatopathological correlates. A scoping review was conducted of all human trials on melasma with histopathologic analysis, including 37 trials in the final analysis. Most studies were conducted on women with a Fitzpatrick skin type of III or greater. Strong histologic evidence supports the utilization of retinols/retinoids for epidermal melasma and microneedling for dermal melasma. There is a paucity of trials conducted on melasma utilizing histologic correlates, and fewer still that are comprehensive to include analyses on quality of life.